keyword
https://read.qxmd.com/read/38656751/circulating-myostatin-levels-as-a-prognostic-biomarker-in-patients-with-acute-liver-failure-and-late-onset-hepatic-failure
#1
JOURNAL ARTICLE
Manabu Hayashi, Kazumichi Abe, Tatsuro Sugaya, Yosuke Takahata, Masashi Fujita, Atsushi Takahashi, Hiromasa Ohira
AIM: Myostatin is a myokine involved in muscle mass regulation. The associations between circulating myostatin levels and clinical characteristics in patients with acute liver failure (ALF) and late-onset hepatic failure (LOHF) are unclear. METHODS: In this retrospective study, 51 patients with ALF or LOHF were included. Serum myostatin was measured using an enzyme-linked immunosorbent assay. RESULTS: Myostatin levels were significantly lower in patients with ALF and LOHF than in controls (ALF/LOHF: 2522 pg/mL, controls: 3853 pg/mL, p = 0...
April 24, 2024: Hepatology Research: the Official Journal of the Japan Society of Hepatology
https://read.qxmd.com/read/38656265/financial-burden-of-cirrhosis-is-significantly-reduced-after-liver-transplantation
#2
JOURNAL ARTICLE
Daniela P Ladner, Charles F Manski
No abstract text is available yet for this article.
April 25, 2024: Liver Transplantation
https://read.qxmd.com/read/38655069/machine-learning-based-predictive-modeling-of-readmissions-following-extracorporeal-membrane-oxygenation-hospitalizations
#3
JOURNAL ARTICLE
Jeffrey Balian, Sara Sakowitz, Arjun Verma, Amulya Vadlakonda, Emma Cruz, Konmal Ali, Peyman Benharash
BACKGROUND: Despite increasing utilization and survival benefit over the last decade, extracorporeal membrane oxygenation (ECMO) remains resource-intensive with significant complications and rehospitalization risk. We thus utilized machine learning (ML) to develop prediction models for 90-day nonelective readmission following ECMO. METHODS: All adult patients receiving ECMO who survived index hospitalization were tabulated from the 2016-2020 Nationwide Readmissions Database...
June 2024: Surgery open science
https://read.qxmd.com/read/38654215/a-challenging-case-of-carbapenem-resistant-klebsiella-pneumoniae-related-pyogenic-liver-abscess-with-capsular-polysaccharide-hyperproduction-a-case-report
#4
JOURNAL ARTICLE
Maryam Sohrabi, Neda Pirbonyeh, Mahvash Alizade Naini, Alireza Rasekhi, Abbas Ayoub, Zahra Hashemizadeh, Fereshteh Shahcheraghi
BACKGROUND: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a major public health problem, necessitating the administration of polymyxin E (colistin) as a last-line antibiotic. Meanwhile, the mortality rate associated with colistin-resistant K. pneumoniae infections is seriously increasing. On the other hand, importance of administration of carbapenems in promoting colistin resistance in K. pneumoniae is unknown. CASE PRESENTATION: We report a case of K...
April 23, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38654041/evaluation-of-liver-transplantation-services-in-kazakhstan-from-2012-to-2023
#5
JOURNAL ARTICLE
Yuliya Semenova, Altynay Beyembetova, Saule Shaisultanova, Aruzhan Asanova, Aliya Sailybayeva, Sholpan Altynova, Yuriy Pya
There is a scarcity of publications evaluating the performance of the national liver transplantation (LTx) program in Kazakhstan. Spanning from 2012 to 2023, it delves into historical trends in LTx surgeries, liver transplant centers, and the national cohort of patients awaiting LTx. Survival analysis for those awaiting LTx, using life tables and Kaplan-Meier, is complemented by time series analysis projecting developments until 2030. The overall per million population (pmp) LTx rate varied from 0.35 to 3.77, predominantly favoring living donor LTx...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38653947/hepatic-and-extrahepatic-characteristics-of-autoimmune-hepatitis-a-23-year-hospital-based-cohort-study
#6
JOURNAL ARTICLE
Ming-Ling Chang, Puo-Hsien Le, Wei-Ting Chen, Tai-Di Chen, Rong-Nan Chien
BACKGROUND: The characteristics of autoimmune hepatitis (AIH) in Asia mostly remain elusive. METHODS: A cohort study of liver biopsy-proven AIH patients was conducted in a tertiary care cancer of Taiwan. RESULTS: From 1999 to 2022, of 13,766 patients who underwent liver biopsy, 150 patients with AIH were enrolled. The female-to-male ratio was 2.26. At baseline, the mean age was 51.09 years, mean alanine aminotransferase level was 494.11 U/L, and 17 (11...
April 23, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38653643/post-infectious-ibs-following-clostridioides-difficile-infection-role-of-microbiota-and-implications-for-treatment
#7
REVIEW
Dana Taghaddos, Zarwa Saqib, Xaiopeng Bai, Premysl Bercik, Stephen M Collins
Up to 25% of patients recovering from antibiotic-treated Clostridioides difficile infection (CDI) develop functional symptoms reminiscent of Post-Infectious Irritable Bowel Syndrome (PI-IBS). For patients with persistent symptoms following infection, a clinical dilemma arises as to whether to provide additional antibiotic treatment or to adopt a conservative symptom-based approach. Here, we review the literature on CDI-related PI-IBS and compare the findings with PI-IBS. We review proposed mechanisms, including the role of C...
April 22, 2024: Digestive and Liver Disease
https://read.qxmd.com/read/38653361/decorin-suppresses-stemness-and-migration-potential-of-malignant-peripheral-nerve-sheath-tumor-through-inhibiting-epidermal-growth-factor-receptor-signaling
#8
JOURNAL ARTICLE
Xiaotian Jia, Lin Chen, Cong Yu
Cancer stem cells (CSCs) play pivotal roles in the growth, invasion, metastasis, chemo-resistance in malignant peripheral nerve sheath tumor (MPNST). The current characterization of CSCs in MPNST is not complete. Decorin is a critical regulator of microenvironment, but its expression and function in CSCs of MPNST has not been studied. In the current study, Decorin levels and its relationship with lung and liver metastasis were determined in clinical specimens. Decorin expression in CD133-positive or CD44-positive CSCs was analyzed by RT-qPCR on cytospun MPNST cells after flow cytometry-based cell sorting...
April 21, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38653337/liver-transplant-vs-liver-resection-in-patients-with-multifocal-hepatocellular-carcinoma
#9
JOURNAL ARTICLE
Hanna Kakish, Mohammed O Suraju, Abhinav Seth, Olivia N DiGioia, Omkar Pawar, Yong K Kwon, Alan W Hemming, Hassan Aziz
BACKGROUND: The optimal surgical option in patients with Multifocal hepatocellular Carcinoma (MHCC) is an area of active research. The preference varies based on geographic variations and institutional policies. We sought to determine long-term outcomes in patients with MHCC based on surgical treatment - Liver transplant (LT) vs resection (LR). METHODS: We performed a retrospective analysis of NCDB (2004-2015) and identified patients with MHCC within Milan criteria...
April 21, 2024: Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38652636/pnpla3-rs738409-age-diabetes-sex-and-advanced-fibrosis-jointly-contribute-to-the-risk-of-major-adverse-liver-outcomes-in-metabolic-associated-steatotic-liver-disease
#10
JOURNAL ARTICLE
Naga Chalasani, Eduardo Vilar-Gomez, Rohit Loomba, Katherine P Yates, Anna Mae Diehl, Brent A Neuschwander-Tetri, Srinivasan Dasarathy, Kris V Kowdley, Norah Terrault, Laura A Wilson, James Tonascia, Arun Sanyal
BACKGROUND AND AIMS: The patatin-like phospholipase domain-containing protein 3 (PNPLA3) rs738409 variant is associated with Steatotic Liver Disease (SLD) and its progression. We examined the association between PNPLA3 and the development of major adverse liver outcomes (MALO) and how non-modifiable and modifiable conditions modify this relationship. APPROACH AND RESULTS: 2,075 adults with biopsy-confirmed Metabolic-Associated SLD (MASLD) were enrolled in the MASLD CRN studies and followed prospectively until death, transplant, or withdrawal of consent...
April 23, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38652391/cardiopulmonary-resuscitation-outcomes-and-trainee-perception-of-code-status-discussions-in-patients-with-cirrhosis
#11
JOURNAL ARTICLE
Margot E Manning, Zachary Fricker
BACKGROUND: Cardiopulmonary resuscitation (CPR) outcomes among patients with cirrhosis are poor, but factors associated with outcomes and provider awareness remain under-evaluated. AIMS: We retrospectively investigated in-hospital CPR mortality among patients with cirrhosis, and, using these results, undertook an educational study among providers to improve knowledge of CPR outcomes and code status in patients with cirrhosis. METHODS: We identified patients with cirrhosis admitted from 2012 to 2022 who underwent CPR at our center; the primary outcome was survival-to-discharge...
April 23, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38651196/advancements-in-medical-research-using-fetal-sheep-implications-for-human-health-and-treatment-methods
#12
REVIEW
Tomoyuki Abe, Borjigin Sarentonglaga, Yoshikazu Nagao
Sheep are typically considered as industrial animals that provide wool and meals. However, they play a significant role in medical research in addition to their conventional use. Notably, sheep fetuses are resistant to surgical invasions and can endure numerous manipulations, such as needle puncture and cell transplantation, and surgical operations requiring exposure beyond the uterus. Based on these distinguishing characteristics, we established a chimeric sheep model capable of producing human/monkey pluripotent cell-derived blood cells via the fetal liver...
2024: Animal Science Journal
https://read.qxmd.com/read/38650933/eltrombopag-can-promote-platelet-implantation-after-allogeneic-hematopoietic-stem-cell-transplantation-as-safely-and-similarly-to-thrombopoietin
#13
JOURNAL ARTICLE
Yahan Li, Fansheng Kong, Guanchen Bai, Yujie Jiang, Wenlu Zhang, Xue Sun, Xiaohui Sui, Ying Li, Mei Ding, Dai Yuan, Xin Wang, Xiaosheng Fang
BACKGROUND: Eltrombopag has demonstrated efficacy in treating low platelet (PLT) levels, but it remains unclear whether eltrombopag can promote PLT engraftment after hematopoietic stem cell transplantation (HSCT). METHODS: Forty-one HSCT patients received eltrombopag 50 mg/d from +1 day until PLT >50 × 109 /L or 1 month after HSCT. Fifty-one patients in the same period received thrombopoietin (TPO) to promote PLT graft after HSCT and served as a control group...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38650799/malignancy-associated-secondary-hemophagocytic-lymphohistiocytosis-mimicking-an-infection-a-case-report-and-review-of-the-literature
#14
Meenakshi Gopalakrishnan, Arunalini Ramanathan, Dhaarani Jayaraman, Sri Gayathri Shanmugam, Julius Xavier Scott
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hematological disorder of immune dysregulation associated with significant challenges in diagnosis and management. Described as primary HLH secondary to genetic defects or more commonly secondary to infections, it can also occur secondary to malignancy, i.e., malignancy-associated hemophagocytic lymphohistiocytosis (M-HLH). A five-year-old male child presented with left cervical adenopathy and a high-spiking fever for two weeks. He had pallor, anasarca, multiple enlarged and matted cervical lymph nodes, respiratory distress, and hepatomegaly...
March 2024: Curēus
https://read.qxmd.com/read/38650519/primary-care-utilization-preventative-screening-and-control-of-metabolic-syndrome-in-metabolic-dysfunction-associated-steatohepatitis-liver-transplant-recipients
#15
JOURNAL ARTICLE
Sarah J Flynn, Varun Saxena, Danielle Brandman
OBJECTIVES: Patients with pre-transplant metabolic dysfunction-associated steatohepatitis (MASH) are at high risk of metabolic syndrome (MetS) after liver transplant. While many patients are co-managed by a transplant team, most preventative screening and MetS management may occur in the primary care setting. We aimed to evaluate primary care utilization by MASH liver transplant recipients as well as MetS screening and control. METHODS: We conducted a retrospective chart review that included adults who underwent liver transplant for MASH or cryptogenic cirrhosis at a single institution from January 2010 to December 2016, had available primary care data, and at least 36-months of follow-up post-transplant...
2024: Journal of Primary Care & Community Health
https://read.qxmd.com/read/38649868/endoscopic-manifestation-of-intestinal-transplant-associated-microangiopathy-after-stem-cell-transplantation
#16
JOURNAL ARTICLE
Masaya Iwamuro, Daisuke Ennishi, Nobuharu Fujii, Ken-Ichi Matsuoka, Takehiro Tanaka, Toshihiro Inokuchi, Sakiko Hiraoka, Motoyuki Otsuka
BACKGROUND: Endoscopic features of intestinal transplant-associated microangiopathy (iTAM) have not been comprehensively investigated. This study aimed to examine the endoscopic characteristics of patients diagnosed with iTAM. METHODS: This retrospective analysis included 14 patients pathologically diagnosed with iTAM after stem cell transplantation for hematolymphoid neoplasms (n = 13) or thalassemia (n = 1). The sex, age at diagnosis, endoscopic features, and prognosis of each patient were assessed...
April 22, 2024: BMC Gastroenterology
https://read.qxmd.com/read/38649493/long-term-outcomes-of-fully-covered-self-expandable-metal-stents-for-refractory-biliary-strictures-after-living-donor-liver-transplantation-a-retrospective-study-at-a-tertiary-center
#17
JOURNAL ARTICLE
Sung Hyun Cho, Ho Seung Lee, Gunn Huh, Dongwook Oh, Tae Jun Song, Dong-Wan Seo, Sung Koo Lee
BACKGROUND AND AIMS: Endoscopic multiple plastic stents are an established first-line treatment for anastomotic biliary stricture (ABS) management after liver transplantation (LT). Fully covered self-expandable metallic stents (FCSEMSs) have recently been used with favorable outcomes, but long-term treatment outcomes remain an issue for ABS. We evaluated the long-term outcomes of FCSEMS for the management of refractory ABS after LT. METHODS: We reviewed the prospectively collected and maintained endoscopic retrograde cholangiography database at Asan Medical Center to retrieve consecutive post-LT ABS cases that underwent an endoscopic FCSEMS placement between August 2009 and August 2019 after MPS placement failure...
April 22, 2024: Surgical Endoscopy
https://read.qxmd.com/read/38649308/two-sides-to-every-story-reappraising-the-early-history-of-liver-transplantation-at-addenbrooke-s-hospital-cambridge
#18
JOURNAL ARTICLE
Peter J Featherstone
Over the course of the past six decades, liver transplantation has evolved to become the treatment of choice for chronic end-stage liver disease and some cases of acute hepatic failure. Currently, more than 34,000 liver transplants are conducted worldwide per annum, and overall one year survival rates exceed 90%. However, the early years of human liver transplantation were beset by failure. Eyewitness reports from this period make for tragic, yet compelling reading. Volume 12 of The History of Anaesthesia Society Proceedings contains one such account, written by Dr Elizabeth Gibbs...
April 22, 2024: Anaesthesia and Intensive Care
https://read.qxmd.com/read/38649218/hyponatremia-in-the-context-of-liver-disease
#19
REVIEW
Amy A Yau, Florian Buchkremer
Hyponatremia is common in patients with liver disease and is associated with increased mortality, morbidity, and a reduced quality of life. In liver transplantation, the inclusion of hyponatremia in organ allocation scores has reduced waitlist mortality. Portal hypertension and the resulting lowering of the effective arterial blood volume are important pathogenetic factors, but in most patients with liver disease, hyponatremia is multifactorial. Treatment requires a multifaceted approach that tries to reduce electrolyte-free water intake, restore urinary dilution, and increase nonelectrolyte solute excretion...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38648751/single-cell-transcriptomics-unveiled-that-early-life-bde-99-exposure-reprogrammed-the-gut-liver-axis-to-promote-a-pro-inflammatory-metabolic-signature-in-male-mice-at-late-adulthood
#20
JOURNAL ARTICLE
Joe Jongpyo Lim, Michael Goedken, Yan Jin, Haiwei Gu, Julia Yue Cui
Polybrominated diphenyl ethers (PBDEs) are legacy flame retardants that bioaccumulate in the environment. The gut microbiome is an important regulator of liver functions including xenobiotic biotransformation and immune regulation. We recently showed that neonatal exposure to polybrominated diphenyl ether-99 (BDE-99), a human breast milk-enriched PBDE congener, up-regulated pro-inflammation- and down-regulated drug metabolism-related genes predominantly in males in young adulthood. However, the persistence of dysregulation into late adulthood, differential impact of hepatic cell types, and the involvement of the gut microbiome from neonatal BDE-99 exposure remains unknown...
April 22, 2024: Toxicological Sciences: An Official Journal of the Society of Toxicology
keyword
keyword
2671
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.